PPL | ||
---|---|---|
OUTLOOK RATING 1..100 | 14 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 54 Fair valued | |
PROFIT vs RISK RATING 1..100 | 32 | |
SMR RATING 1..100 | 79 | |
PRICE GROWTH RATING 1..100 | 54 | |
P/E GROWTH RATING 1..100 | 64 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IGF | PPL | |
---|---|---|
RSI ODDS (%) | 3 days ago76% | N/A |
Stochastic ODDS (%) | 3 days ago80% | 3 days ago60% |
Momentum ODDS (%) | 3 days ago83% | 3 days ago53% |
MACD ODDS (%) | 3 days ago86% | 3 days ago57% |
TrendWeek ODDS (%) | 3 days ago81% | 3 days ago53% |
TrendMonth ODDS (%) | 3 days ago79% | 3 days ago32% |
Advances ODDS (%) | 6 days ago83% | 16 days ago54% |
Declines ODDS (%) | 19 days ago81% | 19 days ago43% |
BollingerBands ODDS (%) | 3 days ago76% | N/A |
Aroon ODDS (%) | 3 days ago80% | 3 days ago29% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QIS | 22.62 | 0.41 | +1.85% |
Simplify Multi-QIS Alternative ETF | |||
VFMF | 137.29 | 1.09 | +0.80% |
Vanguard US Multifactor ETF | |||
ESML | 42.52 | 0.32 | +0.76% |
iShares ESG Aware MSCI USA Small-Cap ETF | |||
FTXH | 26.31 | N/A | +0.01% |
First Trust Nasdaq Pharmaceuticals ETF | |||
FMCE | 26.35 | N/A | N/A |
FM Compounders Equity ETF |
A.I.dvisor indicates that over the last year, IGF has been closely correlated with SRE. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IGF jumps, then SRE could also see price increases.
A.I.dvisor indicates that over the last year, PPL has been closely correlated with AEE. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if PPL jumps, then AEE could also see price increases.